Jeffrey Alan Bubis

机构：Florida Cancer Specialists & Research Institute

发表论文 22 篇 · 总被引 593 次 · h-index 8

代表论文

• Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer (2014 · Journal of Clinical Oncology · 被引 350)
• A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure (2013 · Cytometry Part B Clinical Cytometry · 被引 64)
• Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC). (2011 · Journal of Clinical Oncology · 被引 49)
• A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure (2013 · Cytometry Part B Clinical Cytometry · 被引 40)
• TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer (2017 · Breast Cancer Research and Treatment · 被引 27)
• Docetaxel in the Treatment of Esophageal Cancer (2005 · Seminars in Oncology · 被引 22)